Tor Biering-sørensen
Clinical trials sponsored by Tor Biering-sørensen, explained in plain language.
-
Simple supplements may cut heart failure risks in major new trial
Disease control Recruiting nowThis study tests whether two common supplements—coenzyme Q10 and selenium—can reduce hospitalizations and heart-related deaths in people with heart failure. About 4,044 adults in Denmark will take either the supplements or placebos for two to three years. The goal is to see if th…
Phase: PHASE3 • Sponsor: Tor Biering-Sørensen • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Shingles shot may shield seniors from heart attacks and dementia
Prevention Recruiting nowThis large study in Denmark is testing whether the shingles vaccine (Shingrix) can do more than prevent shingles—it may also lower the risk of heart attacks, strokes, and dementia. About 162,000 adults aged 65 and older will either get the vaccine or no vaccine, and researchers w…
Phase: PHASE4 • Sponsor: Tor Biering-Sørensen • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC